Anti-osteosarcoma trimodal synergistic therapy using NiFe-LDH and MXene nanocomposite for enhanced biocompatibility and efficacy

• Auteurs principaux: Yani Xu (Auteur), Lan Yang (Auteur), Min Li (Auteur), Haozhou Shu (Auteur), Na Jia (Auteur), Yunzhen Gao (Auteur), Rongying Shi (Auteur), Xiaojia Yang (Auteur), Zhirong Zhang (Auteur), Ling Zhang (Auteur)
• Format: Livre
• Publié: Elsevier, 2024-03-01T00:00:00Z.
• Sujets: article
• Accès en ligne: Connect to this object online.

Osteosarcoma is usually resistant to immunotherapy and, thus primarily relies on surgical resection and high-dosage chemotherapy. Unfortunately, less invasive or toxic therapies such as photothermal therapy (PTT) and chemodynamic therapy (CDT) generally failed to show satisfactory outcomes. Adequate...